BioCorRx Inc (BICX)
OTHER OTC:BICX
US Market

BioCorRx (BICX) Stock Price & Analysis

5 Followers

BICX Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$0.35 - $2.16
Previous Close$0.71
Volume32.00
Average Volume (3M)1.75K
Market Cap
$6.87M
Enterprise Value$8.85M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$2.11M
Price to Earnings (P/E)
Beta-0.11
Aug 12, 2024
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.46
Shares Outstanding9,612,703
10 Day Avg. Volume2,015
30 Day Avg. Volume1,750
Standard Deviation0.23
R-Squared0.02
Alpha-0.01
Financial Highlights & Ratios
Price to Book (P/B)-0.52
Price to Sales (P/S)53.91
Price to Cash Flow (P/CF)-3.40
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue119.94
Enterprise Value/Gross Profit166.45
Enterprise Value/Ebitda-2.92
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0

Financials

Annual

Options Prices

Currently, No data available
---

Ownership Overview

12.94%0.00%0.00%87.06%
12.94% Insiders
0.00% Other Institutional Investors
87.06% Public Companies and
Individual Investors

BICX FAQ

What was BioCorRx Inc’s price range in the past 12 months?
BioCorRx Inc lowest stock price was $0.35 and its highest was $2.16 in the past 12 months.
    What is BioCorRx Inc’s market cap?
    Currently, no data Available
    When is BioCorRx Inc’s upcoming earnings report date?
    BioCorRx Inc’s upcoming earnings report date is Aug 12, 2024 which is in 14 days.
      How were BioCorRx Inc’s earnings last quarter?
      BioCorRx Inc released its earnings results on May 14, 2024. The company reported -$0.141 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.141.
        Is BioCorRx Inc overvalued?
        According to Wall Street analysts BioCorRx Inc’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
          Does BioCorRx Inc pay dividends?
          BioCorRx Inc does not currently pay dividends.
          What is BioCorRx Inc’s EPS estimate?
          BioCorRx Inc’s EPS estimate for its next earnings report is not yet available.
          How many shares outstanding does BioCorRx Inc have?
          BioCorRx Inc has 9,612,703 shares outstanding.
            What happened to BioCorRx Inc’s price movement after its last earnings report?
            BioCorRx Inc reported an EPS of -$0.141 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
              Which hedge fund is a major shareholder of BioCorRx Inc?
              Currently, no hedge funds are holding shares in BICX
              ---

              BioCorRx Stock Smart Score

              10
              Unlock Smart Score
              1
              2
              3
              4
              5
              6
              7
              8
              9
              10

              Technicals

              SMA
              Negative
              20 days / 200 days
              Momentum
              -65.83%
              12-Months-Change

              Fundamentals

              Return on Equity
              Trailing 12-Months
              Asset Growth
              -55.24%
              Trailing 12-Months

              Company Description

              BioCorRx Inc

              BioCorRx, Inc. engages in the provision of alcoholism and opioid addiction treatment. It offers treatment philosophy that combines medical intervention and a proprietary cognitive behavioral therapy program specifically tailored for the treatment of alcoholism and other substance abuse addictions for those receiving long-term naltrexone treatment. It also engages in the research and development of sustained release naltrexone products for the treatment of addiction and other possible disorders. The company was founded by Neil Terrence Muller and George O'Neill on January 28, 2008 and is headquartered in Anaheim, CA.
              ---
              Similar Stocks
              Company
              Price & Change
              Follow
              Axsome Therapeutics
              Aclaris Therapeutics
              Esperion
              Sorrento Therapeutics
              Popular Stocks
              ---
              What's Included in PREMIUM?
              Make informed decisions based on Top Analysts' activity
              Know what industry insiders are buying
              Get actionable alerts from top Wall Street Analysts
              Find out before anyone else which stock is going to shoot up
              Get powerful stock screeners & detailed portfolio analysis